IgGenix
Scott Smith is a Scientific Advisor at IgGenix. Scott has over 15 years of experience in the pharmaceutical industry, including stints as a Chief Development Officer and Vice President of Clinical Development. Scott has also served as a Principal Medical Director and Global Development Team Leader. In addition to their work in the pharmaceutical industry, Scott is also a Professor at Harvard Medical School.
Scott Smith has an MD and PhD from Harvard Medical School. Scott is currently a resident at Boston Children's Hospital. Scott is also Board Certified in Pediatrics and in Allergy/Immunology.
This person is not in the org chart
This person is not in any offices
IgGenix
IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. They work on translating research discoveries into transformative therapies for individuals suffering from allergies.